title: Olmesartan: induced maculopapular rash.
abstract: Olmesartan medoxomil is an angiotensin receptor blocker (ARB) which is shown to be effective and well tolerated in hypertensive patients. It is a frequently prescribed antihypertensive as it is considered safe. Here, we report the case of a patient who developed maculopapular rash during the course of the treatment with olmesartan medoxomil.
authors.affiliation: Department of Pharmacology and Surgery, BIMS College, Belgaum, Karnataka, India.
authors.forename: Aruna
authors.initials: A
authors.lastname: Bhushan
authors.forename: S T
authors.initials: ST
authors.lastname: Ved Bhushan
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan
keywords: Angiotensin receptor blockers; maculopapular rash; olmesartan